Research and Development Team
About
The Research and Development Team at QurAlis is dedicated to advancing the understanding and treatment of ALS by investigating the underlying mechanisms of the disease. Comprising a diverse group of scientific experts, the team collaborates to develop targeted therapeutics, design and conduct experiments, and analyze data to identify potential pathways for intervention. Their work aims to translate innovative research into precision medicine solutions that improve the lives of ALS patients.
Team members
Bernhardt L. Trout
Scientific Advisor
Brian J. Wainger
Scientific Advisor
Christopher Shaw
Scientific Advisor
Clifford Woolf
Scientific Advisor
Daniel Elbaum
Chief Scientific Officer
Kevin Eggan
Scientific Advisor
Marisa Kamelgarn
Senior Scientist
Matthew Kiernan
Scientific Advisor
Michael McMillan
Scientist I
Michelle Hastings
Scientific Advisor
Other teams at QurAlis
View all